DAWN- Day One Biopharmaceuticals, Inc.

Name: Day One Biopharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bender Jeremy	355.0K	$7.64M	-
CFO	York Charles N II	188.0K	$4.05M	-
Other	Vasconcelles Michael	171.0K	$3.68M	-
Other	Dubow Adam	105.0K	$2.26M	-
Other	Merendino Lauren	74.0K	$1.59M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 10, 2023	Blackman Samuel C.77	Chief Medical Officer	Sell	10,000	$22.86	$228,643.75	-0.4%	-44.3%	-38.7%
Jan 3, 2023	Grant Julie Papanek78	Director	Sell	25,000	$20.65	$516,147.12	-3.2%	-35.2%	-30.8%
Dec 21, 2022	Bender Jeremy76	Chief Executive Officer	Sell	12,500	$20.32	$253,968.75	-1.0%	-13.0%	-30.9%
Dec 20, 2022	York Charles N II76	COO, CFO And Secretary	Sell	10,000	$20.07	$200,650.00	-3.5%	-10.0%	-32.1%
Dec 8, 2022	Grant Julie Papanek78	Director	Sell	4,358	$22.08	$96,210.26	-1.1%	-11.9%	-44.1%
Dec 2, 2022	Grant Julie Papanek78	Director	Sell	10,000	$21.65	$216,480.39	-0.8%	-15.4%	-43.6%
Dec 1, 2022	Blackman Samuel C.77	Chief Medical Officer	Sell	10,000	$21.45	$214,529.89	-0.4%	-12.4%	-42.2%
Nov 21, 2022	York Charles N II76	COO, CFO And Secretary	Sell	10,000	$20.76	$207,569.78	-1.7%	-5.9%	-41.6%
Nov 21, 2022	Bender Jeremy76	Chief Executive Officer	Sell	12,500	$20.76	$259,479.38	-0.5%	-5.9%	-41.6%
Nov 16, 2022	York Charles N II76	COO, CFO And Secretary	Sale+OE	430	$21.46	$9,227.71	-0.1%	-6.0%	-44.7%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC